We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+7.37%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$38.4B
AUM Growth
-$1.19B
(-3%)
Cap. Flow
-$4.36B
Cap. Flow
% of AUM
-11.34%
Top 10 Holdings %
Top 10 Hldgs %
12.21%
Holding
2,288
New
283
Increased
703
Reduced
824
Closed
345
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$205M |
| 2 |
Biogen
BIIB
|
+$167M |
| 3 |
Exelon
EXC
|
+$81.9M |
| 4 |
Deckers Outdoor
DECK
|
+$78.9M |
| 5 |
Intuit
INTU
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$298M |
| 2 |
Microsoft
MSFT
|
+$238M |
| 3 |
NVIDIA
NVDA
|
+$230M |
| 4 |
SBA Communications
SBAC
|
+$159M |
| 5 |
Amazon
AMZN
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Consumer Discretionary | 11.68% |
| 3 | Healthcare | 10.92% |
| 4 | Financials | 10.59% |
| 5 | Industrials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Kontoor Brands
KTB
$4.62B
| $17.4M | 0.05% |
212,705
+34,926
| +20% | +$2.49M |
|
477
Quest Diagnostics
DGX
$25.1B
| $17.4M | 0.05% |
111,903
-84,173
| -43% | -$12.6M |
|
478
HealthEquity
HQY
$7.91B
| $17.4M | 0.05% |
212,097
+172,950
| +442% | +$13.3M |
|
|
AXON
479
Axon Enterprise
AXON
$40.5B
| $17.3M | 0.05% |
43,300
-59,793
| -58% | -$20.6M |
|
480
Southern Company
SO
$110B
| $17.3M | 0.05% |
191,785
+124,496
| +185% | +$10.6M |
|
481
Erie Indemnity
ERIE
$11.7B
| $17.3M | 0.05% |
32,031
-1,713
| -5% | -$780K |
|
482
Matador Resources
MTDR
$6.31B
| $17.2M | 0.04% |
348,322
+143,398
| +70% | +$8.08M |
|
|
ONC
483
BeOne Medicines Ltd
ONC
$33.8B
| $17.1M | 0.04% |
76,227
+67,050
| +731% | +$12.1M |
|
484
Acuity Brands
AYI
$9.88B
| $17.1M | 0.04% |
61,992
-39,619
| -39% | -$9.85M |
|
|
ECHO
485
PUT
EchoStar
ECHO
$25.5B
| $17.1M | 0.04% |
687,100
+700
| +0.1% | +$14.3K |
|
486
Abbott
ABT
$180B
| $16.9M | 0.04% |
148,488
-160,797
| -52% | -$17.6M |
|
487
Applovin
APP
$132B
| $16.9M | 0.04% |
129,531
+67,111
| +108% | +$6.12M |
|
488
Seagate
STX
$193B
| $16.8M | 0.04% |
153,077
-256,196
| -63% | -$26.2M |
|
|
DAY
489
DELISTED
Dayforce
DAY
| $16.7M | 0.04% |
+272,547
| New | +$15M |
|
490
Tyler Technologies
TYL
$12.2B
| $16.7M | 0.04% |
28,561
+14,818
| +108% | +$8.34M |
|
491
United Therapeutics
UTHR
$26.3B
| $16.6M | 0.04% |
46,421
-28,898
| -38% | -$9.76M |
|
492
Dr. Reddy's Laboratories
RDY
$9.82B
| $16.6M | 0.04% |
1,042,695
+439,820
| +73% | +$7.08M |
|
493
Celanese
CE
$5.09B
| $16.5M | 0.04% |
121,319
+31,199
| +35% | +$4.1M |
|
494
PUT
AbbVie
ABBV
$458B
| $16.5M | 0.04% |
83,500
+38,800
| +87% | +$7.24M |
|
495
Alaska Air
ALK
$5.15B
| $16.4M | 0.04% |
363,401
+351,304
| +2,904% | +$13.3M |
|
496
Coca-Cola Europacific Partners
CCEP
$46.5B
| $16.4M | 0.04% |
208,614
+3,108
| +2% | +$238K |
|
497
Brown & Brown
BRO
$22.9B
| $16.3M | 0.04% |
157,582
+32,713
| +26% | +$3.25M |
|
498
Corcept Therapeutics
CORT
$10.2B
| $16.2M | 0.04% |
350,533
-479,410
| -58% | -$17M |
|
499
Nucor
NUE
$56.4B
| $16.2M | 0.04% |
107,713
-34,608
| -24% | -$5.21M |
|
500
Rockwell Automation
ROK
$51.4B
| $16.2M | 0.04% |
60,253
+37,181
| +161% | +$9.87M |
|
Similar funds
Man Group's Q3 2024 Portfolio in Review
As of Q3 2024, Man Group held 2,288 positions worth $38.4B, down 3% from $39.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Man Group withdrew a net $4.36B in Q3 2024, closing 345 positions and reducing 824 holdings. Its most notable exit was Endeavor Group Holdings, Inc., an estimated $54.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Man Group opened a new position in Transmedics worth $54.2M.
- Man Group's largest Q3 2024 buy was Transmedics: 345,320 shares worth $54.2M.
- Man Group added most to Amphenol in Q3 2024, an estimated $205M increase.
- Man Group's biggest Q3 2024 reduction was Apple, cutting an estimated $298M.
- Man Group fully exited Endeavor Group Holdings, Inc. in Q3 2024, selling an estimated $54.4M.
- Man Group's ten largest holdings make up 12% of its $38.4B portfolio in Q3 2024.
- Man Group opened 283 new positions and closed 345 in Q3 2024.
- Man Group's portfolio value fell 3% quarter-over-quarter to $38.4B.
Based on Man Group's 13F filing for Q3 2024, filed 14 Nov 2024.